Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Quidelortho Corp (QDEL)

Quidelortho Corp (QDEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,691,625
  • Shares Outstanding, K 67,257
  • Annual Sales, $ 2,998 M
  • Annual Income, $ -10,100 K
  • EBIT $ 130 M
  • EBITDA $ 587 M
  • 60-Month Beta 0.12
  • Price/Sales 0.92
  • Price/Cash Flow 3.91
  • Price/Book 0.91

Options Overview Details

View History
  • Implied Volatility 46.72% ( -0.38%)
  • Historical Volatility 44.68%
  • IV Percentile 46%
  • IV Rank 19.57%
  • IV High 84.71% on 07/25/24
  • IV Low 37.48% on 01/12/24
  • Put/Call Vol Ratio 37.74
  • Today's Volume 2,208
  • Volume Avg (30-Day) 318
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 7,392
  • Open Int (30-Day) 6,031

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 1.06
  • Number of Estimates 3
  • High Estimate 1.14
  • Low Estimate 0.99
  • Prior Year 1.17
  • Growth Rate Est. (year over year) -9.40%

Price Performance

See More
Period Period Low Period High Performance
1-Month
38.02 +5.26%
on 10/31/24
46.00 -13.00%
on 11/08/24
-1.03 (-2.51%)
since 10/11/24
3-Month
38.02 +5.26%
on 10/31/24
47.62 -15.96%
on 09/18/24
-3.26 (-7.53%)
since 08/13/24
52-Week
29.74 +34.59%
on 07/10/24
75.86 -47.24%
on 12/27/23
-18.38 (-31.47%)
since 11/13/23

Most Recent Stories

More News
QuidelOrtho: Q3 Earnings Snapshot

QuidelOrtho: Q3 Earnings Snapshot

QDEL : 40.02 (-2.72%)
Why QuidelOrtho Stock Blasted 10% Higher Today

The healthcare company has significant and untapped earnings potential, asserts one pundit.

QDEL : 40.02 (-2.72%)
QuidelOrtho: Q2 Earnings Snapshot

QuidelOrtho: Q2 Earnings Snapshot

QDEL : 40.02 (-2.72%)
Why QuidelOrtho Stock Is Crashing Today

The in vitro diagnostics company had a lot of bad news in its Q4 update.

QDEL : 40.02 (-2.72%)
Powerful Lyme Disease Awareness PSA Featuring Christopher Meloni Illuminates Times Square

/PRNewswire/ -- In an inspiring and emotional display of solidarity for Lyme disease awareness, a striking public service announcement (PSA) has taken center...

QDEL : 40.02 (-2.72%)
QuidelOrtho Reports First Quarter 2023 Financial Results

QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and...

QDEL : 40.02 (-2.72%)
Why QuidelOrtho Stock Popped by 5% on Friday

It looks like the company's first quarter is going to please investors greatly.

QDEL : 40.02 (-2.72%)
QuidelOrtho Reports Preliminary Revenue Results for the First Quarter 2023

QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and...

QDEL : 40.02 (-2.72%)
QuidelOrtho Announces the Formation of the International QuidelOrtho Women’s Leadership Network (QWLN)

QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine,...

QDEL : 40.02 (-2.72%)
QuidelOrtho Receives De Novo FDA Authorization for Sofia® 2 SARS Antigen+ FIA

QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine,...

QDEL : 40.02 (-2.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases,...

See More

Key Turning Points

3rd Resistance Point 43.08
2nd Resistance Point 42.19
1st Resistance Point 41.10
Last Price 40.02
1st Support Level 39.13
2nd Support Level 38.24
3rd Support Level 37.15

See More

52-Week High 75.86
Fibonacci 61.8% 58.24
Fibonacci 50% 52.80
Fibonacci 38.2% 47.35
Last Price 40.02
52-Week Low 29.74

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar